PCNSL is characterized by recurrent genomic features, including loss of HLA loci located at 6p21.32–p25.3, amplification of 9p24 including the PD-L1 locus, and MYD88 L265P and CD79B Y196 hotspot mutations [3]. This evidence concerns the gene MYD88 and primary central nervous system lymphoma.